Can improvement in delivery of smoking cessation care be sustained in psychiatry inpatient settings through a system change intervention? An analysis of statewide administrative health data.

Systems change psychiatry inpatient serious mental illness smoking cessation sustainability

Journal

The Australian and New Zealand journal of psychiatry
ISSN: 1440-1614
Titre abrégé: Aust N Z J Psychiatry
Pays: England
ID NLM: 0111052

Informations de publication

Date de publication:
10 2023
Historique:
medline: 25 9 2023
pubmed: 12 4 2023
entrez: 11 4 2023
Statut: ppublish

Résumé

This study evaluated maintenance of improved delivery of smoking cessation assistance in adult acute psychiatry inpatient units 3 years post statewide implementation of a system change intervention through analysis of a statewide administrative health dataset. Rates of documenting smoking status and providing a brief smoking cessation intervention (the Smoking Cessation Clinical Pathway) in all eligible Queensland public adult acute psychiatry inpatient units ( Across implementation and maintenance phases, the percentage of discharges from psychiatry inpatient units that had a smoking status recorded remained high with the statewide average exceeding 90% (implementation phase 93.2%, 95% confidence interval = [92.4, 93.9]; and maintenance phase 94.6%, 95% confidence interval = [94.0, 95.2]). The percentage of discharges statewide with a completed Pathway stabilised during the maintenance phase (change in slope -3.7%, 95% confidence interval = [-5.2, -2.3]; change in level 0.4%, 95% confidence interval = [-7.0, 7.9]). An evidence-based smoking cessation intervention implemented with a system change intervention resulted in sustained improvement in addressing smoking in adult inpatient psychiatry units up to 3 years post implementation.

Identifiants

pubmed: 37038343
doi: 10.1177/00048674231164566
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1375-1383

Auteurs

Sally Plever (S)

The QLD Mental Health Clinical Collaborative, Metro North Mental Health, Brisbane, QLD, Australia.
School of Public Health, The University of Queensland, Brisbane, QLD, Australia.
NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame (Tobacco Endgame CRE), The University of Queensland, Brisbane, QLD, Australia.

Steve Kisely (S)

Department of Psychiatry, School of Clinical Medicine, The University of Queensland, Brisbane, QLD, Australia.
Metro South Addiction and Mental Health Service, Brisbane, QLD, Australia.

Billie Bonevski (B)

School of Public Health, The University of Queensland, Brisbane, QLD, Australia.
NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame (Tobacco Endgame CRE), The University of Queensland, Brisbane, QLD, Australia.
Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia.

Irene McCarthy (I)

The QLD Mental Health Clinical Collaborative, Metro North Mental Health, Brisbane, QLD, Australia.

Brett Emmerson (B)

The QLD Mental Health Clinical Collaborative, Metro North Mental Health, Brisbane, QLD, Australia.

Emma Ballard (E)

QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Melissa Anzolin (M)

The QLD Mental Health Clinical Collaborative, Metro North Mental Health, Brisbane, QLD, Australia.

Dan Siskind (D)

NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame (Tobacco Endgame CRE), The University of Queensland, Brisbane, QLD, Australia.
Department of Psychiatry, School of Clinical Medicine, The University of Queensland, Brisbane, QLD, Australia.

John Allan (J)

Mental Health Alcohol and Other Drugs Branch, Clinical Excellence Queensland, Queensland Health, Brisbane, QLD, Australia.

Coral Gartner (C)

School of Public Health, The University of Queensland, Brisbane, QLD, Australia.
NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame (Tobacco Endgame CRE), The University of Queensland, Brisbane, QLD, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH